Impact Biomedical IBO
NYSE IBO
$3.80 -0.31 (-7.54%)
At close: Oct 22, 2026 · 4:00 PM EDT

Impact Biomedical (IBO) Change in Receivables (2025 - 2026)

Updated

Impact Biomedical (IBO) posted Change in Receivables of -$5,000 for Q1 2026.

Analysis

Impact Biomedical (IBO) Change in Receivables (2025 - 2026) Analysis & Trends

For FY2025, Impact Biomedical's Change in Receivables came in at $1,000.

  • In prior years, Impact Biomedical's Change in Receivables was -$128,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -188.00 Mn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 1.37 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 333.00 Mn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Impact Biomedical 397.86 Mn 397.82 Mn 2,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -5,000.00
Dec 31, 2025 -10,000.00
Sep 30, 2025 15,000.00
API Access

Impact Biomedical Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=IBO&period=max&api_key=YOUR_API_KEY